InfoBionic, Inc., a Lowell, MA-based digital health company focused on creating patient monitoring solutions for chronic disease management, raised an $8m Series B-1 financing.
The round was led by Safeguard Scientifics (NYSE:SFE) with participation from existing shareholders Excel Venture Management; Zaffre Investments, a subsidiary of Blue Cross Blue Shield of Massachusetts; and various angels.
The company intends to use the funds to commercialize its MoMe® Kardia system.
Led by Nancy Briefs, President, CEO and Co-Founder, InfoBionic provides the MoMe® Kardia system, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection. Its remote patient monitoring platform delivers on-demand, actionable monitoring data and analytics for Holter, Event, and MCT directly to physicians. It streams continuous electrocardiogram, respiration and motion data to the cloud for analysis and delivers automated reporting to any mobile device, tablet or web-based portal where physicians can access and interact with the data they need.